Cite

HARVARD Citation

    Omura, M. et al. (2022). First successful case of platinum‐based chemotherapy for neuroendocrine prostate cancer with BRCA2 and PTEN alterations. IJU case reports. 5 (1), pp. 41-44. [Online]. 
  
Back to record